GnRH Agonist as Luteal Support in FET Cycles

Summary

Back ground: A single dose of GnRH analogue in the luteal phase is reported to improve the outcome of IVF/ICSI treatments but the effect in FET cycles has not been reported. Aim: To compare the results of frozen thawed embryo transfers with and without GnRHa analogue support Primary end point: IR, PR, on going PR Secondary end point: hCH, E2 and progesterone levels 14 days after thawing

Timeline

Start

2013-05

Primary completion

2015-04

Completion

2015-10

Drugs

Indications